{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["herbal medicines, HMGB1, coronaviruses, SARS-CoV, respiratory system"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32629817", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "16"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["4639", "10.3390/ijms21134639"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "13", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "30"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.", "Abstract": {"AbstractText": ["By attaching to the angiotensin converting enzyme 2 (ACE2) protein on lung and intestinal cells, Sudden Acute Respiratory Syndrome (SARS-CoV-2) can cause respiratory and homeostatic difficulties leading to sepsis. The progression from acute respiratory failure to sepsis has been correlated with the release of high-mobility group box 1 protein (HMGB1). Lack of effective conventional treatment of this septic state has spiked an interest in alternative medicine. This review of herbal extracts has identified multiple candidates which can target the release of HMGB1 and potentially reduce mortality by preventing progression from respiratory distress to sepsis. Some of the identified mixtures have also been shown to interfere with viral attachment. Due to the wide variability in chemical superstructure of the components of assorted herbal extracts, common motifs have been identified. Looking at the most active compounds in each extract it becomes evident that as a group, phenolic compounds have a broad enzyme inhibiting function. They have been shown to act against the priming of SARS-CoV-2 attachment proteins by host and viral enzymes, and the release of HMGB1 by host immune cells. An argument for the value in a nonspecific inhibitory action has been drawn. Hopefully these findings can drive future drug development and clinical procedures."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair of Department of Dental Surgery and Periodontology, Poznan University of Medicinal Sciences, Bukowska 70, 60-812 Poznan, Poland."}], "LastName": "Wyganowska-Swiatkowska", "ForeName": "Marzena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair of Department of Dental Surgery and Periodontology, Poznan University of Medicinal Sciences, Bukowska 70, 60-812 Poznan, Poland."}], "LastName": "Nohawica", "ForeName": "Michal", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interdisciplinary Dentistry, Pomeranian Medical University, Al. Powstancow Wlkp. 72, 70-111 Szczecin, Poland."}], "LastName": "Grocholewicz", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Cosmetic Natural Products, Poznan University of Medicinal Sciences, Mazowiecka 33, 60-623 Poznan, Poland."}], "LastName": "Nowak", "ForeName": "Gerard", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "HMGB1 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Exudates"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["physiology"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "HMGB1 Protein"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["cytology", "metabolism", "virology"], "DescriptorName": "Macrophages"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Exudates"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism", "pathology", "prevention & control"], "DescriptorName": "Respiratory Insufficiency"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["metabolism", "pathology", "prevention & control"], "DescriptorName": "Sepsis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Louten J. Virus Structure and Classification. Essent. Hum. Virol. 2016:19\u201329. doi: 10.1016/B978-0-12-800947-5.00002-8.", "ArticleIdList": ["10.1016/B978-0-12-800947-5.00002-8"]}, {"Citation": "Elena S.F., Sanju\u00e1n R. Adaptive Value of High Mutation Rates of RNA Viruses: Separating Causes from Consequences. J. Virol. 2005;79:11555\u201311558. doi: 10.1128/JVI.79.18.11555-11558.2005.", "ArticleIdList": ["10.1128/JVI.79.18.11555-11558.2005", "PMC1212614", "16140732"]}, {"Citation": "Simon-Loriere E., Holmes E.C. Why do RNA viruses recombine? Nat. Rev. Genet. 2011;9:617\u2013626. doi: 10.1038/nrmicro2614.", "ArticleIdList": ["10.1038/nrmicro2614", "PMC3324781", "21725337"]}, {"Citation": "Ghenkina D.B., Ghendon Y.Z. Recombination and complementation between orthomyxoviruses under conditions of abortive infection. Acta Virol. 1979;23:97\u2013106.", "ArticleIdList": ["39444"]}, {"Citation": "Cohen J. Why is the flu vaccine so mediocre? Science. 2017;357:1222\u20131223. doi: 10.1126/science.357.6357.1222.", "ArticleIdList": ["10.1126/science.357.6357.1222", "28935783"]}, {"Citation": "Lin L.-T., Hsu W.-C., Lin C.-C. Antiviral Natural Products and Herbal Medicines. J. Tradit. Complementary Med. 2014;4:24\u201335. doi: 10.4103/2225-4110.124335.", "ArticleIdList": ["10.4103/2225-4110.124335", "PMC4032839", "24872930"]}, {"Citation": "Holmes K.V. CORONAVIRUSES (CORONAVIRIDAE) Encycl. Virol. 2004:291\u2013298. doi: 10.1006/rwvi.1999.0055.", "ArticleIdList": ["10.1006/rwvi.1999.0055"]}, {"Citation": "Woo P.C.Y., Lau S.K.P., Lam C.S.F., Lau C.C.Y., Tsang A.K.L., Lau J.H.N., Bai R., Teng J.L.L., Tsang C.C.C., Wang M., et al. Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus. J. Virol. 2012;86:3995\u20134008. doi: 10.1128/jvi.06540-11.", "ArticleIdList": ["10.1128/jvi.06540-11", "PMC3302495", "22278237"]}, {"Citation": "Raoult D., Zumla A., Locatelli F., Ippolito G., Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020;4:66\u201375. doi: 10.15698/cst2020.04.216.", "ArticleIdList": ["10.15698/cst2020.04.216", "PMC7064018", "32292881"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054\u20131062. doi: 10.1016/S0140-6736(20)30566-3.", "ArticleIdList": ["10.1016/S0140-6736(20)30566-3", "PMC7270627", "32171076"]}, {"Citation": "Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. COVID-19, SARS and MERS: Are they closely related? Clin. Microbiol. Infect. 2020;26:729\u2013734. doi: 10.1016/j.cmi.2020.03.026.", "ArticleIdList": ["10.1016/j.cmi.2020.03.026", "PMC7176926", "32234451"]}, {"Citation": "Xu Y., Li X., Zhu B., Liang H., Fang C., Gong Y., Guo Q., Sun X., Zhao D., Shen J., et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat. Med. 2020;26:502\u2013505. doi: 10.1038/s41591-020-0817-4.", "ArticleIdList": ["10.1038/s41591-020-0817-4", "PMC7095102", "32284613"]}, {"Citation": "Zhong J., Tang J., Ye C., Dong L. The immunology of COVID-19: Is immune modulation an option for treatment? Lancet Rheumatol. 2020 doi: 10.1016/S2665-9913(20)30120-X.", "ArticleIdList": ["10.1016/S2665-9913(20)30120-X", "PMC7239618", "32835246"]}, {"Citation": "Sun S., Cai X., Wang H., He G., Lin Y., Lu B., Chen C., Pan Y., Hu X. Abnormalities of Peripheral Blood System in Patients with COVID-19 in Wenzhou, China. Clin. Chim. Acta. 2020;507:174\u2013180. doi: 10.1016/j.cca.2020.04.024.", "ArticleIdList": ["10.1016/j.cca.2020.04.024", "PMC7194694", "32339487"]}, {"Citation": "Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Wang Y., Guo X. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12:244. doi: 10.3390/v12020244.", "ArticleIdList": ["10.3390/v12020244", "PMC7077191", "32098422"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271\u2013280.e8. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Matsuyama S., Nagata N., Shirato K., Kawase M., Takeda M., Taguchi F. Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2. J. Virol. 2010;84:12658\u201312664. doi: 10.1128/JVI.01542-10.", "ArticleIdList": ["10.1128/JVI.01542-10", "PMC3004351", "20926566"]}, {"Citation": "Bertram S., Heurich A., Lavender H., Gierer S., Danisch S., Perin P., Lucas J.M., Nelson P.S., P\u00f6hlmann S., Soilleux E. Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts. PLoS ONE. 2012;7:e35876. doi: 10.1371/journal.pone.0035876.", "ArticleIdList": ["10.1371/journal.pone.0035876", "PMC3340400", "22558251"]}, {"Citation": "Imai Y., Kuba K., Penninger J.M. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp. Physiol. 2008;93:543\u2013548. doi: 10.1113/expphysiol.2007.040048.", "ArticleIdList": ["10.1113/expphysiol.2007.040048", "PMC7197898", "18448662"]}, {"Citation": "Jia H. Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease. Shock. 2016;46:239\u2013248. doi: 10.1097/SHK.0000000000000633.", "ArticleIdList": ["10.1097/SHK.0000000000000633", "27082314"]}, {"Citation": "Sl\u00e1dkov\u00e1 T., Kostolansk\u00fd F. The role of cytokines in the immune response to influenza a virus infection. Acta Virol. 2006;50:151\u2013162.", "ArticleIdList": ["17131933"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Lin G.-L., McGinley J.P., Drysdale S.B., Pollard A.J. Epidemiology and Immune Pathogenesis of Viral Sepsis. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.02147.", "ArticleIdList": ["10.3389/fimmu.2018.02147", "PMC6170629", "30319615"]}, {"Citation": "Tay M.Z., Poh C.M., Renia L., Macary P.A., Ng L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20:363\u2013374. doi: 10.1038/s41577-020-0311-8.", "ArticleIdList": ["10.1038/s41577-020-0311-8", "PMC7187672", "32346093"]}, {"Citation": "Banerjee D., Popoola J., Shah S., Ster I.C., Quan V., Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97:1076\u20131082. doi: 10.1016/j.kint.2020.03.018.", "ArticleIdList": ["10.1016/j.kint.2020.03.018", "PMC7142878", "32354637"]}, {"Citation": "Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003;22:5551\u20135560. doi: 10.1093/emboj/cdg516.", "ArticleIdList": ["10.1093/emboj/cdg516", "PMC213771", "14532127"]}, {"Citation": "Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., Susarla S., Czura C., Mitchell R.A., Chen G., et al. IFN-\u03b3 Induces High Mobility Group Box 1 Protein Release Partly through a TNF-Dependent Mechanism. J. Immunol. 2003;170:3890\u20133897. doi: 10.4049/jimmunol.170.7.3890.", "ArticleIdList": ["10.4049/jimmunol.170.7.3890", "12646658"]}, {"Citation": "Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002;3:995\u20131001. doi: 10.1093/embo-reports/kvf198.", "ArticleIdList": ["10.1093/embo-reports/kvf198", "PMC1307617", "12231511"]}, {"Citation": "Chu J.J.H., Ng M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 2003;84:3305\u20133314. doi: 10.1099/vir.0.19447-0.", "ArticleIdList": ["10.1099/vir.0.19447-0", "14645911"]}, {"Citation": "Joseph T., Cepica A., Brown L., Ikede B.O., Kibenge F.S.B. Mechanism of cell death during infectious salmon anemia virus infection is cell type-specific. J. Gen. Virol. 2004;85:3027\u20133036. doi: 10.1099/vir.0.80091-0.", "ArticleIdList": ["10.1099/vir.0.80091-0", "15448366"]}, {"Citation": "Chen L.-C., Yeh T.-M., Wu H.-N., Lin Y.-Y., Shyu H.-W. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. J. Infect. 2008;56:143\u2013150. doi: 10.1016/j.jinf.2007.10.008.", "ArticleIdList": ["10.1016/j.jinf.2007.10.008", "18076993"]}, {"Citation": "Alleva L.M., Budd A.C., Clark I.A. Systemic release of high mobility group box 1 protein during severe murine influenza. J. Immunol. 2008;181:1454\u20131459. doi: 10.4049/jimmunol.181.2.1454.", "ArticleIdList": ["10.4049/jimmunol.181.2.1454", "18606700"]}, {"Citation": "Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., et al. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice. Science. 1999;285:248\u2013251. doi: 10.1126/science.285.5425.248.", "ArticleIdList": ["10.1126/science.285.5425.248", "10398600"]}, {"Citation": "Chen G., Chen D.-Z., Li J., Czura C.J., Tracey K.J., Sama A.E., Wang H. Pathogenic role of HMGB1 in SARS? Med. Hypotheses. 2004;63:691\u2013695. doi: 10.1016/j.mehy.2004.01.037.", "ArticleIdList": ["10.1016/j.mehy.2004.01.037", "PMC7127179", "15325019"]}, {"Citation": "Wang H., Yang H., Tracey K.J. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 2004;255:320\u2013331. doi: 10.1111/j.1365-2796.2003.01302.x.", "ArticleIdList": ["10.1111/j.1365-2796.2003.01302.x", "14871456"]}, {"Citation": "Chen G., Ward M., Sama A.E., Wang H. Extracellular HMGB1 as a Proinflammatory Cytokine. J. Interf. Cytokine Res. 2004;24:329\u2013333. doi: 10.1089/107999004323142187.", "ArticleIdList": ["10.1089/107999004323142187", "15212706"]}, {"Citation": "Huttunen H., Rauvala H. Amphoterin as an extracellular regulator of cell motility: From discovery to disease. J. Intern. Med. 2004;255:351\u2013366. doi: 10.1111/j.1365-2796.2003.01301.x.", "ArticleIdList": ["10.1111/j.1365-2796.2003.01301.x", "14871459"]}, {"Citation": "Gul F., Arslantas M.K., Cinel I., Kumar A. Changing Definitions of Sepsis. Turk. J. Anaesthesiol. Reanim. 2017;45:129\u2013138. doi: 10.5152/TJAR.2017.93753.", "ArticleIdList": ["10.5152/TJAR.2017.93753", "PMC5512390", "28752002"]}, {"Citation": "Srikrishna G., Nayak J., Weigle B., Temme A., Foell D., Hazelwood L., Olsson A., Volkmann N., Hanein R., Freeze H.H. Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J. Cell. Biochem. 2010;110:645\u2013659. doi: 10.1002/jcb.22575.", "ArticleIdList": ["10.1002/jcb.22575", "PMC2879712", "20512925"]}, {"Citation": "Hao W., Ma B., Li Z., Wang X., Gao X., Li Y., Qin B., Shang S., Cui S., Tan Z. Binding of the SARS-CoV-2 Spike Protein to Glycans. bioRxiv. 2020 doi: 10.1101/2020.05.17.100537.", "ArticleIdList": ["10.1101/2020.05.17.100537", "PMC7816574", "33495714"]}, {"Citation": "Walls A.C., Xiong X., Park Y.-J., Tortorici M.A., Snijder J., Quispe J., Cameroni E., Gopal R., Dai M., Lanzavecchia A., et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2019;176:1026\u20131039.e15. doi: 10.1016/j.cell.2018.12.028.", "ArticleIdList": ["10.1016/j.cell.2018.12.028", "PMC6751136", "30712865"]}, {"Citation": "Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u2013454. doi: 10.1038/nature02145.", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G., et al. Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction. N. Engl. J. Med. 1992;327:669\u2013677. doi: 10.1056/NEJM199209033271001.", "ArticleIdList": ["10.1056/NEJM199209033271001", "1386652"]}, {"Citation": "Li N., Zimpelmann J., Cheng K., Wilkins J.A., Burns K.D. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1\u20137 by rat proximal tubules. Am. J. Physiol. Physiol. 2005;288:F353\u2013F362. doi: 10.1152/ajprenal.00144.2004.", "ArticleIdList": ["10.1152/ajprenal.00144.2004", "15467007"]}, {"Citation": "Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112\u2013116. doi: 10.1038/nature03712.", "ArticleIdList": ["10.1038/nature03712", "PMC7094998", "16001071"]}, {"Citation": "Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation. 2005;111:2605\u20132610. doi: 10.1161/CIRCULATIONAHA.104.510461.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.104.510461", "15897343"]}, {"Citation": "Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000;52:673\u2013751.", "ArticleIdList": ["11121513"]}, {"Citation": "Nijveldt R.J., Van Nood E., Van Hoorn D.E., Boelens P.G., Van Norren K., Van Leeuwen P.A. Flavonoids: A review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001;74:418\u2013425. doi: 10.1093/ajcn/74.4.418.", "ArticleIdList": ["10.1093/ajcn/74.4.418", "11566638"]}, {"Citation": "Frankel E., German J., Kinsella J., Parks E., Kanner J. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454\u2013457. doi: 10.1016/0140-6736(93)90206-V.", "ArticleIdList": ["10.1016/0140-6736(93)90206-V", "8094487"]}, {"Citation": "De Pascual-Teresa S., Santos-Buelga C., Rivas-Gonzalo J.-C. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J. Agric. Food Chem. 2000;48:5331\u20135337. doi: 10.1021/jf000549h.", "ArticleIdList": ["10.1021/jf000549h", "11087482"]}, {"Citation": "Arts I.C.W., Van De Putte B., Hollman P.C.H. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J. Agric. Food Chem. 2000;48:1752\u20131757. doi: 10.1021/jf000026+.", "ArticleIdList": ["10.1021/jf000026+", "10820090"]}, {"Citation": "Actis-Goretta L., Ottaviani J.I., Fraga C.G. Inhibition of Angiotensin Converting Enzyme Activity by Flavanol-Rich Foods. J. Agric. Food Chem. 2006;54:229\u2013234. doi: 10.1021/jf052263o.", "ArticleIdList": ["10.1021/jf052263o", "16390204"]}, {"Citation": "Boath A.S., Stewart D., McDougall G.J. Berry components inhibit \u03b1-glucosidase in vitro: Synergies between acarbose and polyphenols from black currant and rowanberry. Food Chem. 2012;135:929\u2013936. doi: 10.1016/j.foodchem.2012.06.065.", "ArticleIdList": ["10.1016/j.foodchem.2012.06.065", "22953807"]}, {"Citation": "Lochocka K., Bajerska J., Glapa A., Fidler-Witon E., Nowak J.K., Szczapa T., Grebowiec P., Lisowska A., Walkowiak J. Green tea extract decreases starch digestion and absorption from a test meal in humans: A randomized, placebo-controlled crossover study. Sci. Rep. 2015;5:1\u20135. doi: 10.1038/srep12015.", "ArticleIdList": ["10.1038/srep12015", "PMC4520190", "26226166"]}, {"Citation": "Sakulnarmrat K., Srzednicki G., Konczak I. Composition and inhibitory activities towards digestive enzymes of polyphenolic-rich fractions of Davidson\u2019s plum and quandong. LWT Food Sci. Technol. 2014;57:366\u2013375. doi: 10.1016/j.lwt.2014.01.002.", "ArticleIdList": ["10.1016/j.lwt.2014.01.002"]}, {"Citation": "Cirkovic-Velickovic T., Stanic-Vucinic D. The Role of Dietary Phenolic Compounds in Protein Digestion and Processing Technologies to Improve Their Antinutritive Properties. Compr. Rev. Food Sci. Food Saf. 2017;17:82\u2013103. doi: 10.1111/1541-4337.12320.", "ArticleIdList": ["10.1111/1541-4337.12320", "33350063"]}, {"Citation": "Polakovic M., Handrikov\u00e1 G., Ko\u0161\u00edk M. Inhibitory effects of some phenolic compounds on enzymatic hydrolysis of sucrose. Biomass Bioenergy. 1992;3:369\u2013371. doi: 10.1016/0961-9534(92)90010-N.", "ArticleIdList": ["10.1016/0961-9534(92)90010-N"]}, {"Citation": "Bhowmik D., Nandi R., Kumar D. Evaluation of Flavonoids as 2019-NCoV Cell Entry Inhibitor through Molecular Docking and Pharmacological Analysis. Chem. Rxiv. 2020 doi: 10.26434/chemrxiv.12071508.v1.", "ArticleIdList": ["10.26434/chemrxiv.12071508.v1", "PMC7955945", "33748510"]}, {"Citation": "Liu H., Ye F., Sun Q., Liang H., Li C., Lu R., Huang B., Tan W., Lai L. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. bioRxiv. 2020 doi: 10.1101/2020.04.10.035824.", "ArticleIdList": ["10.1101/2020.04.10.035824", "PMC7850424", "33491508"]}, {"Citation": "Yu M.-S., Lee J., Lee J.M., Kim Y., Chin Y.-W., Jee J.-G., Keum Y.-S., Jeong Y.-J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorganic Med. Chem. Lett. 2012;22:4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Glowacka I., Bertram S., M\u00fcller M.A., Allen P., Soilleux E., Pfefferle S., Steffen I., Tsegaye T.S., He Y., Gnirss K., et al. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response. J. Virol. 2011;85:4122\u20134134. doi: 10.1128/JVI.02232-10.", "ArticleIdList": ["10.1128/JVI.02232-10", "PMC3126222", "21325420"]}, {"Citation": "Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1\u201312. doi: 10.1038/s41467-020-15562-9.", "ArticleIdList": ["10.1038/s41467-020-15562-9", "PMC7100515", "32221306"]}, {"Citation": "Shirato K., Kawase M., Matsuyama S. Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2. J. Virol. 2013;87:12552\u201312561. doi: 10.1128/JVI.01890-13.", "ArticleIdList": ["10.1128/JVI.01890-13", "PMC3838146", "24027332"]}, {"Citation": "Tang D., Kang R., Van Houten B., Zeh H.J., Billiar T.R., Lotze M.T. High Mobility Group Box 1 (HMGB1) Phenotypic Role Revealed with Stress. Mol. Med. 2014;20:359\u2013362. doi: 10.2119/molmed.2014.00063.", "ArticleIdList": ["10.2119/molmed.2014.00063", "PMC4153844", "24937773"]}, {"Citation": "Stevens N., Chapman M.J., Fraser C.K., Kuchel T.R., Hayball J., Diener K.R. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes. Sci. Rep. 2017;7:1\u201314. doi: 10.1038/s41598-017-06205-z.", "ArticleIdList": ["10.1038/s41598-017-06205-z", "PMC5517568", "28724977"]}, {"Citation": "Charoensup J., Sermswan R.W., Paeyao A., Promakhejohn S., Punasee S., Chularari C., Krabkraikaew S., Lertanekawattana S., Wongratanacheewin S. High HMGB1 level is associated with poor outcome of septicemic melioidosis. Int. J. Infect. Dis. 2014;28:111\u2013116. doi: 10.1016/j.ijid.2014.07.025.", "ArticleIdList": ["10.1016/j.ijid.2014.07.025", "25263503"]}, {"Citation": "Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation. J. Immunol. 2000;165:2950\u20132954. doi: 10.4049/jimmunol.165.6.2950.", "ArticleIdList": ["10.4049/jimmunol.165.6.2950", "10975801"]}, {"Citation": "Jin Y.-H., Cai L., Cheng Z.-S., Cheng H., Deng T., Fan Y.-P., Fang C., Huang D., Huang L.-Q., Huang Q., et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil. Med Res. 2020;7:4. doi: 10.1186/s40779-020-0233-6.", "ArticleIdList": ["10.1186/s40779-020-0233-6", "PMC7003341", "32029004"]}, {"Citation": "Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., Kobayashi A., Maruyama I., Yamada S., Hasegawa N., et al. Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury. Am. J. Respir. Crit. Care Med. 2004;170:1310\u20131316. doi: 10.1164/rccm.200402-188OC.", "ArticleIdList": ["10.1164/rccm.200402-188OC", "15374839"]}, {"Citation": "Ma W.-X., Ran X.-W. The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51:146\u2013150.", "ArticleIdList": ["32220179"]}, {"Citation": "Kosai K., Seki M., Yanagihara K., Nakamura S., Kurihara S., Izumikawa K., Kakeya H., Yamamoto Y., Tashiro T., Kohno S. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand. J. Infect. Dis. 2008;40:338\u2013342. doi: 10.1080/00365540701660486.", "ArticleIdList": ["10.1080/00365540701660486", "17918013"]}, {"Citation": "Lee N., Wong C.K., Chan P.K., Chan M.C.W., Wong R.Y.K., Lun S.W.M., Ngai K.L.K., Lui G., Wong B.C.K., Lee S.K.W., et al. Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults. PLoS ONE. 2011;6:e26050. doi: 10.1371/journal.pone.0026050.", "ArticleIdList": ["10.1371/journal.pone.0026050", "PMC3192778", "22022504"]}, {"Citation": "Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004;10:1216\u20131221. doi: 10.1038/nm1124.", "ArticleIdList": ["10.1038/nm1124", "15502843"]}, {"Citation": "Wang H., Li W., Li J., Rendon-Mitchell B., Ochani M., Ashok M., Yang L., Yang H., Tracey K.J., Wang P., et al. The Aqueous Extract of a Popular Herbal Nutrient Supplement, Angelica sinensis, Protects Mice against Lethal Endotoxemia and Sepsis12. J. Nutr. 2006;136:360\u2013365. doi: 10.1093/jn/136.2.360.", "ArticleIdList": ["10.1093/jn/136.2.360", "PMC1766946", "16424112"]}, {"Citation": "Czura C.J., Wang H., Tracey K.J. Dual roles for HMGB1: DNA binding and cytokine. J. Endotoxin Res. 2001;7:315\u2013321. doi: 10.1177/09680519010070041401.", "ArticleIdList": ["10.1177/09680519010070041401", "11717586"]}, {"Citation": "Yang H., Wang H., Tracey K.J. HMG-1 REDISCOVERED AS A CYTOKINE. Shock. 2001;15:247\u2013253. doi: 10.1097/00024382-200115040-00001.", "ArticleIdList": ["10.1097/00024382-200115040-00001", "11303722"]}, {"Citation": "Yang T., Jia M., Zhou S., Pan F., Mei Q. Antivirus and immune enhancement activities of sulfated polysaccharide from Angelica sinensis. Int. J. Biol. Macromol. 2012;50:768\u2013772. doi: 10.1016/j.ijbiomac.2011.11.027.", "ArticleIdList": ["10.1016/j.ijbiomac.2011.11.027", "22155400"]}, {"Citation": "Ichimura T., Otake T., Mori H., Maruyama S. HIV-1 Protease Inhibition and Anti-HIV Effect of Natural and Synthetic Water-soluble Lignin-like Substances. Biosci. Biotechnol. Biochem. 1999;63:2202\u20132204. doi: 10.1271/bbb.63.2202.", "ArticleIdList": ["10.1271/bbb.63.2202", "10664853"]}, {"Citation": "Li W., Li J., Ashok M., Wu R., Chen D., Yang L., Yang H., Tracey K.J., Wang P., Sama A.E., et al. A Cardiovascular Drug Rescues Mice from Lethal Sepsis by Selectively Attenuating a Late-Acting Proinflammatory Mediator, High Mobility Group Box 11. J. Immunol. 2007;178:3856\u20133864. doi: 10.4049/jimmunol.178.6.3856.", "ArticleIdList": ["10.4049/jimmunol.178.6.3856", "PMC2041900", "17339485"]}, {"Citation": "Wu B.-W., Pan T.-L., Leu Y.-L., Chang Y.-K., Tai P.-J., Lin K.-H., Horng J.-T. Antiviral Effects ofSalvia miltiorrhiza(Danshen) Against Enterovirus 71. Am. J. Chin. Med. 2007;35:153\u2013168. doi: 10.1142/S0192415X07004709.", "ArticleIdList": ["10.1142/S0192415X07004709", "17265559"]}, {"Citation": "Duan S.-P., Zhu L.-H., Li P., Song X.-W., Wang H.-W., Shen B.-S. Effect and mechanism of danshensu on hepatitis B virus reverse transcriptase and antigen expression. Zhongguo Zhong Yao Za Zhi. 2016;41:1297\u20131301. doi: 10.4268/cjcmm20160722.", "ArticleIdList": ["10.4268/cjcmm20160722", "28879746"]}, {"Citation": "Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992;21:334\u2013350. doi: 10.1016/0091-7435(92)90041-F.", "ArticleIdList": ["10.1016/0091-7435(92)90041-F", "1614995"]}, {"Citation": "Chacko S.M., Thambi P.T., Kuttan R., Nishigaki I. Beneficial effects of green tea: A literature review. Chin. Med. 2010;5:1\u20139. doi: 10.1186/1749-8546-5-13.", "ArticleIdList": ["10.1186/1749-8546-5-13", "PMC2855614", "20370896"]}, {"Citation": "Yang C.S., Wang H. Cancer Preventive Activities of Tea Catechins. Molecules. 2016;21:1679. doi: 10.3390/molecules21121679.", "ArticleIdList": ["10.3390/molecules21121679", "PMC6273642", "27941682"]}, {"Citation": "Li W., Ashok M., Li J., Yang H., Sama A.E., Wang H. A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1. PLoS ONE. 2007;2:e1153. doi: 10.1371/journal.pone.0001153.", "ArticleIdList": ["10.1371/journal.pone.0001153", "PMC2048740", "17987129"]}, {"Citation": "Chen X., Li W., Wang H. More tea for septic patients?\u2014Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines. Med. Hypotheses. 2005;66:660\u2013663. doi: 10.1016/j.mehy.2005.09.025.", "ArticleIdList": ["10.1016/j.mehy.2005.09.025", "PMC1447554", "16266789"]}, {"Citation": "Hong J., Lu H., Meng X., Ryu J.-H., Hara Y., Yang C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002;62:7241\u20137246.", "ArticleIdList": ["12499265"]}, {"Citation": "Tachibana H., Fujimura Y., Yamada K. Tea polyphenol epigallocatechin-3-gallate associates with plasma membrane lipid rafts: Lipid rafts mediate anti-allergic action of the catechin. BioFactors. 2004;21:383\u2013385. doi: 10.1002/biof.552210174.", "ArticleIdList": ["10.1002/biof.552210174", "15630231"]}, {"Citation": "Tachibana H., Koga K., Fujimura Y., Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 2004;11:380\u2013381. doi: 10.1038/nsmb743.", "ArticleIdList": ["10.1038/nsmb743", "15024383"]}, {"Citation": "Fujimura Y., Tachibana H., Yamada K. Lipid raft-associated catechin suppresses the Fc\u03f5RI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2. FEBS Lett. 2003;556:204\u2013210. doi: 10.1016/S0014-5793(03)01432-7.", "ArticleIdList": ["10.1016/S0014-5793(03)01432-7", "14706851"]}, {"Citation": "Triantafilou M., Miyake K., Golenbock U.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002;115:2603\u20132611.", "ArticleIdList": ["12045230"]}, {"Citation": "Ide K., Kawasaki Y., Kawakami K., Yamada H. Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review. Curr. Med. Chem. 2016;23:4773\u20134783. doi: 10.2174/0929867324666161123091010.", "ArticleIdList": ["10.2174/0929867324666161123091010", "27881069"]}, {"Citation": "Xu J., Xu Z., Zheng W. A Review of the Antiviral Role of Green Tea Catechins. Molecules. 2017;22:1337. doi: 10.3390/molecules22081337.", "ArticleIdList": ["10.3390/molecules22081337", "PMC6152177", "28805687"]}, {"Citation": "Shen X., Zhang X., Liu S. Novel hemagglutinin-based influenza virus inhibitors. J. Thorac. Dis. 2013;5:S149\u2013S159.", "ArticleIdList": ["PMC3747528", "23977436"]}, {"Citation": "Furushima D., Ide K., Yamada H. Effect of Tea Catechins on Influenza Infection and the Common Cold with a Focus on Epidemiological/Clinical Studies. Molecules. 2018;23:1795. doi: 10.3390/molecules23071795.", "ArticleIdList": ["10.3390/molecules23071795", "PMC6100025", "30037024"]}, {"Citation": "Huang X., Dong W., Milewska A., Golda A., Qi Y., Zhu Q.K., Marasco W.A., Baric R.S., Sims A.C., Pyrc K., et al. Human Coronavirus HKU1 Spike Protein UsesO-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme. J. Virol. 2015;89:7202\u20137213. doi: 10.1128/JVI.00854-15.", "ArticleIdList": ["10.1128/JVI.00854-15", "PMC4473545", "25926653"]}, {"Citation": "Huang H.-C., Tao M.-H., Hung T.-M., Chen J.-C., Lin Z.-J., Huang C. (\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antivir. Res. 2014;111:100\u2013111. doi: 10.1016/j.antiviral.2014.09.009.", "ArticleIdList": ["10.1016/j.antiviral.2014.09.009", "25260897"]}, {"Citation": "Colpitts C.C., Schang L.M. A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans. J. Virol. 2014;88:7806\u20137817. doi: 10.1128/JVI.00896-14.", "ArticleIdList": ["10.1128/JVI.00896-14", "PMC4097786", "24789779"]}, {"Citation": "ElFiky A.A. Ebola virus glycoprotein GP1\u2014Host cell-surface HSPA5 binding site prediction. Cell Stress Chaperones. 2020;25:541\u2013548. doi: 10.1007/s12192-020-01106-z.", "ArticleIdList": ["10.1007/s12192-020-01106-z", "PMC7154572", "32291698"]}, {"Citation": "Reid S.P., Shurtleff A.C., Costantino J.A., Tritsch S.R., Retterer C., Spurgers K.B., Bavari S. HSPA5 is an essential host factor for Ebola virus infection. Antivir. Res. 2014;109:171\u2013174. doi: 10.1016/j.antiviral.2014.07.004.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.004", "25017472"]}, {"Citation": "Lee W., Cho S.-H., Kim J.-E., Lee C., Lee J.-H., Baek M.-C., Song G.Y., Bae J.-S. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses. Am. J. Chin. Med. 2019;47:119\u2013133. doi: 10.1142/S0192415X1950006X.", "ArticleIdList": ["10.1142/S0192415X1950006X", "30630344"]}, {"Citation": "Lim D.-S., Bae K., Jung I., Kim C., Yun Y., Song J.-Y. Anti-Septicaemic Effect of Polysaccharide from Panax ginseng by Macrophage Activation. J. Infect. 2002;45:32\u201338. doi: 10.1053/jinf.2002.1007.", "ArticleIdList": ["10.1053/jinf.2002.1007", "12217729"]}, {"Citation": "Zhang J., Wang J., Wu X., Wei Y. Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells. Artif. Cells Nanomed. Biotechnol. 2019;47:2967\u20132971. doi: 10.1080/21691401.2019.1643732.", "ArticleIdList": ["10.1080/21691401.2019.1643732", "31313594"]}, {"Citation": "Dong W., Farooqui A., Le\u00f3n A.J., Kelvin D.J. Inhibition of influenza A virus infection by ginsenosides. PLoS ONE. 2017;12:e0171936. doi: 10.1371/journal.pone.0171936.", "ArticleIdList": ["10.1371/journal.pone.0171936", "PMC5302443", "28187149"]}, {"Citation": "Adianti M., Aoki C., Komoto M., Deng L., Shoji I., Wahyuni T.S., Lusida M.I., Soetjipto, Fuchino H., Kawahara N., et al. Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species. Microbiol. Immunol. 2014;58:180\u2013187. doi: 10.1111/1348-0421.12127.", "ArticleIdList": ["10.1111/1348-0421.12127", "PMC7168410", "24397541"]}, {"Citation": "Huang W., Chen X., Li Q., Li P., Zhao G., Xu M., Xie P. Inhibition of Intercellular Adhesion in Herpex Simplex Virus Infection by Glycyrrhizin. Cell Biophys. 2011;62:137\u2013140. doi: 10.1007/s12013-011-9271-8.", "ArticleIdList": ["10.1007/s12013-011-9271-8", "21874590"]}, {"Citation": "Velusami C.C., Deepak H., Thiyagarajan P., Kathiresan S., Sangli G.K., Deepak M., Agarwal A. Dual inhibitory effect of Glycyrrhiza glabra (GutGard\u2122) on COX and LOX products. Phytomedicine. 2011;18:278\u2013284. doi: 10.1016/j.phymed.2010.08.001.", "ArticleIdList": ["10.1016/j.phymed.2010.08.001", "20864324"]}, {"Citation": "Wu T.-Y., Khor T.O., Saw C., Loh S.C., Chen A.I., Lim S.S., Park J.H.Y., Cai L., Kong A.-N. Anti-inflammatory/Anti-oxidative Stress Activities and Differential Regulation of Nrf2-Mediated Genes by Non-Polar Fractions of Tea Chrysanthemum zawadskii and Licorice Glycyrrhiza uralensis. AAPS J. 2010;13:1\u201313. doi: 10.1208/s12248-010-9239-4.", "ArticleIdList": ["10.1208/s12248-010-9239-4", "PMC3032091", "20967519"]}, {"Citation": "Wang L., Yang R., Yuan B., Liu Y., Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm. Sin. B. 2015;5:310\u2013315. doi: 10.1016/j.apsb.2015.05.005.", "ArticleIdList": ["10.1016/j.apsb.2015.05.005", "PMC4629407", "26579460"]}, {"Citation": "Chen D., Bellussi L.M., Cocca S., Wang J., Passali G.C., Hao X., Chen L., Passali D. Glycyrrhetinic acid suppressed hmgb1 release by up-regulation of Sirt6 in nasal inflammation. J. Biol. Regul. Homeost. Agents. 2017;31:269\u2013277.", "ArticleIdList": ["28685526"]}, {"Citation": "Qu L., Chen C., He W., Chen Y., Li Y., Wen Y., Zhou S., Jiang Y., Yang X., Zhang R., et al. Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. Am. J. Transl. Res. 2019;11:2042\u20132055.", "ArticleIdList": ["PMC6511780", "31105816"]}, {"Citation": "Ciprandi G., Bellussi L.M., Passali G.C., Damiani V., Passali D. HMGB1 in nasal inflammatory diseases: A reappraisal 30 years after its discovery. Expert Rev. Clin. Immunol. 2020:1\u20137. doi: 10.1080/1744666X.2020.1752668.", "ArticleIdList": ["10.1080/1744666X.2020.1752668", "32252560"]}, {"Citation": "Zheng Y.-J., Zhou B., Song Z.-F., Li L., Wu J., Zhang R.-Y., Tang Y.-Q. Study of Astragalus mongholicus polysaccharides on endothelial cells permeability induced by HMGB1. Carbohydr. Polym. 2013;92:934\u2013941. doi: 10.1016/j.carbpol.2012.08.001.", "ArticleIdList": ["10.1016/j.carbpol.2012.08.001", "23218386"]}, {"Citation": "Yang E.-J., Ku S.-K., Lee W., Lee S., Lee T., Song K.-S., Bae J.-S. Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo. J. Cell. Physiol. 2013;228:975\u2013982. doi: 10.1002/jcp.24243.", "ArticleIdList": ["10.1002/jcp.24243", "23042518"]}, {"Citation": "Swarup V., Ghosh J., Ghosh S., Saxena A., Basu A. Antiviral and Anti-Inflammatory Effects of Rosmarinic Acid in an Experimental Murine Model of Japanese Encephalitis. Antimicrob. Agents Chemother. 2007;51:3367\u20133370. doi: 10.1128/AAC.00041-07.", "ArticleIdList": ["10.1128/AAC.00041-07", "PMC2043228", "17576830"]}, {"Citation": "Tabba H.D., Chang R., Smith K.M. Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antivir. Res. 1989;11:263\u2013273. doi: 10.1016/0166-3542(89)90036-3.", "ArticleIdList": ["10.1016/0166-3542(89)90036-3", "2802570"]}, {"Citation": "Psotova J., Kol\u00e1\u0159 M., Sousek J., \u0160vagera Z., Vicar J., Ulrichov\u00e1 J. Biological activities ofPrunella vulgarisextract. Phytother. Res. 2003;17:1082\u20131087. doi: 10.1002/ptr.1324.", "ArticleIdList": ["10.1002/ptr.1324", "14595592"]}, {"Citation": "Tsoyi K., Jang H.J., Kim J.W., Chang H.K., Lee Y.S., Pae H.-O., Kim H.J., Seo H.G., Lee J.H., Chung H.-T., et al. Stimulation of Alpha7 Nicotinic Acetylcholine Receptor by Nicotine Attenuates Inflammatory Response in Macrophages and Improves Survival in Experimental Model of Sepsis Through Heme Oxygenase-1 Induction. Antioxid. Redox Signal. 2011;14:2057\u20132070. doi: 10.1089/ars.2010.3555.", "ArticleIdList": ["10.1089/ars.2010.3555", "21083424"]}, {"Citation": "Jun M.S., Kim H.S., Kim Y.M., Kim H.J., Park E.J., Lee J.H., Lee K.R., Kim Y.S., Chang K.C. Ethanol Extract of Prunella vulgaris var. lilacina Inhibits HMGB1 Release by Induction of Heme Oxygenase-1 in LPS-activated RAW 264.7 Cells and CLP-induced Septic Mice. Phytother. Res. 2011;26:605\u2013612. doi: 10.1002/ptr.3613.", "ArticleIdList": ["10.1002/ptr.3613", "21971692"]}, {"Citation": "Raafat K., Wurglics M., Schubert-Zsilavecz M. Prunella vulgaris L. active components and their hypoglycemic and antinociceptive effects in alloxan-induced diabetic mice. Biomed. Pharm. 2016;84:1008\u20131018. doi: 10.1016/j.biopha.2016.09.095.", "ArticleIdList": ["10.1016/j.biopha.2016.09.095", "27768926"]}, {"Citation": "Oh C., Price J., A Brindley M., Widrlechner M.P., Qu L., McCoy J.-A., Murphy P.A., Hauck C., Maury W. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol. J. 2011;8:188. doi: 10.1186/1743-422X-8-188.", "ArticleIdList": ["10.1186/1743-422X-8-188", "PMC3096947", "21513560"]}, {"Citation": "Lee W., Kim K.-M., Bae J.-S. Ameliorative Effect of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) on HMGB1-Induced Septic Responses in Vitro and In Vivo. Am. J. Chin. Med. 2015;43:991\u20131012. doi: 10.1142/S0192415X15500573.", "ArticleIdList": ["10.1142/S0192415X15500573", "26224030"]}, {"Citation": "Rahmasari R., Haruyama T., Charyasriwong S., Nishida T., Kobayashi N. Antiviral Activity of Aspalathus linearis against Human Influenza Virus. Nat. Prod. Commun. 2017;12:599\u2013602. doi: 10.1177/1934578X1701200432.", "ArticleIdList": ["10.1177/1934578X1701200432", "30520604"]}, {"Citation": "Lee W., Yoon E.-K., Kim K.-M., Park D.H., Bae J.-S. Antiseptic effect of vicenin-2 and scolymoside from Cyclopia subternata (honeybush) in response to HMGB1 as a late sepsis mediator in vitro and in vivo. Can. J. Physiol. Pharmacol. 2015;93:709\u2013720. doi: 10.1139/cjpp-2015-0021.", "ArticleIdList": ["10.1139/cjpp-2015-0021", "26243020"]}, {"Citation": "Park S.H., Roh E., Kim H.S., Baek S.-I., Choi N.S., Kim N., Hwang B.Y., Han S.-B., Kim Y. Inhibition of IRAK-4 activity for rescuing endotoxin LPS-induced septic mortality in mice by lonicerae flos extract. Biochem. Biophys. Res. Commun. 2013;442:183\u2013188. doi: 10.1016/j.bbrc.2013.11.045.", "ArticleIdList": ["10.1016/j.bbrc.2013.11.045", "24269819"]}, {"Citation": "Lee C.-H., Yoon S.-J., Lee S.-M. Chlorogenic Acid Attenuates High Mobility Group Box 1 (HMGB1) and Enhances Host Defense Mechanisms in Murine Sepsis. Mol. Med. 2012;18:1437\u20131448. doi: 10.2119/molmed.2012.00279.", "ArticleIdList": ["10.2119/molmed.2012.00279", "PMC3563707", "23168580"]}, {"Citation": "Park E.J., Kim Y.M., Park S.W., Kim H.J., Lee J.H., Lee D.-U., Chang K.C. Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice. Food Chem. Toxicol. 2013;55:386\u2013395. doi: 10.1016/j.fct.2012.12.027.", "ArticleIdList": ["10.1016/j.fct.2012.12.027", "23298677"]}, {"Citation": "Gierlikowska B., Gierlikowski W., Bekier K., Skalicka-Wo\u017aniak K., Czerwi\u0144ska M.E., Kiss A.K., Michalak B. Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium. J. Ethnopharmacol. 2020;249:112311. doi: 10.1016/j.jep.2019.112311.", "ArticleIdList": ["10.1016/j.jep.2019.112311", "31644941"]}, {"Citation": "Qi Z., Zhang Y., Qi S., Ling L., Gui L., Yan L., Lv J., Li Q. Salidroside Inhibits HMGB1 Acetylation and Release through Upregulation of SirT1 during Inflammation. Oxidative Med. Cell. Longev. 2017;2017:9821543. doi: 10.1155/2017/9821543.", "ArticleIdList": ["10.1155/2017/9821543", "PMC5733170", "29333216"]}, {"Citation": "Lan K.-C., Chao S.-C., Wu H.-Y., Chiang C.-L., Wang C.-C., Liu S.-H., Weng T.-I. Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-\u03baB and HMGB1 pathways through the upregulation of SIRT1. Sci. Rep. 2017;7:1\u201311. doi: 10.1038/s41598-017-12285-8.", "ArticleIdList": ["10.1038/s41598-017-12285-8", "PMC5607272", "28931916"]}, {"Citation": "Yang E.-J., Lee W., Song K.-S., Bae J.-S. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo. Biochem. Pharmacol. 2016;110:58\u201370. doi: 10.1016/j.bcp.2016.04.006.", "ArticleIdList": ["10.1016/j.bcp.2016.04.006", "27106082"]}, {"Citation": "Shang J., Liu W., Yin C., Chu H., Zhang M. Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-\u03baB signaling. Mol. Immunol. 2019;114:571\u2013577. doi: 10.1016/j.molimm.2019.09.008.", "ArticleIdList": ["10.1016/j.molimm.2019.09.008", "31525576"]}, {"Citation": "Luo J.-X., Zhang Y., Hu X.-Y., Chen G., Liu X.-Y., Nie H.-M., Liu J.-L., Wen D.-C. Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-\u039aB/caspase-3 and PCNA signaling pathways. J. Ethnopharmacol. 2016;183:187\u2013192. doi: 10.1016/j.jep.2016.01.020.", "ArticleIdList": ["10.1016/j.jep.2016.01.020", "26806574"]}, {"Citation": "Yu M., Yang Y.-X., Shu X.-Y., Huang J., Hou D.-B. Aconitum carmichaelii Debeaux, cultivated as a medicinal plant in western China. Genet. Resour. Crop. Evol. 2016;63:919\u2013924. doi: 10.1007/s10722-016-0398-8.", "ArticleIdList": ["10.1007/s10722-016-0398-8"]}, {"Citation": "Zaki A.M., El-Tanbouly D.M., El Salam R.A., Zaki H.F. Plumbagin ameliorates hepatic ischemia-reperfusion injury in rats: Role of high mobility group box 1 in inflammation, oxidative stress and apoptosis. Biomed. Pharmacother. 2018;106:785\u2013793. doi: 10.1016/j.biopha.2018.07.004.", "ArticleIdList": ["10.1016/j.biopha.2018.07.004", "29990872"]}, {"Citation": "Yang Y.-I., Woo J.-H., Seo Y.-J., Lee K.-T., Lim Y., Choi J.-H. Protective Effect of Brown Alga Phlorotannins against Hyper-inflammatory Responses in Lipopolysaccharide-Induced Sepsis Models. J. Agric. Food Chem. 2016;64:570\u2013578. doi: 10.1021/acs.jafc.5b04482.", "ArticleIdList": ["10.1021/acs.jafc.5b04482", "26730445"]}, {"Citation": "Park J.-Y., Kim J.H., Kwon J.M., Kwon H.-J., Jeong H.J., Kim Y.M., Kim D., Lee W.S., Ryu Y.B. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorganic Med. Chem. 2013;21:3730\u20133737. doi: 10.1016/j.bmc.2013.04.026.", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Qamar M.T.U., Alqahtani S.M., Alamri M.A., Chen L.-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020 doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "D\u2019Eliseo D., Pannucci E., Bernini R., Campo M., Romani A., Santi L., Velotti F. In vitro studies on anti-inflammatory activities of kiwifruit peel extract in human THP-1 monocytes. J. Ethnopharmacol. 2019;233:41\u201346. doi: 10.1016/j.jep.2018.12.044.", "ArticleIdList": ["10.1016/j.jep.2018.12.044", "30599220"]}, {"Citation": "Min G., Ku S.-K., Park M.S., Park T.J., Lee H.-S., Bae J.-S. Anti-septic effects of pelargonidin on HMGB1-induced responses in vitro and in vivo. Arch. Pharmacal Res. 2016;39:1726\u20131738. doi: 10.1007/s12272-016-0834-5.", "ArticleIdList": ["10.1007/s12272-016-0834-5", "27778275"]}, {"Citation": "Chen D., Bi A., Dong X., Jiang Y., Rui B., Liu J., Yin Z., Luo L. Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. Biochem. Biophys. Res. Commun. 2014;443:326\u2013332. doi: 10.1016/j.bbrc.2013.11.122.", "ArticleIdList": ["10.1016/j.bbrc.2013.11.122", "24321097"]}, {"Citation": "Wang L., Chen J., Wang B., Wu D., Li H., Lu H., Wu H., Chai Y. Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Exp. Biol. Med. 2014;239:1653\u20131662. doi: 10.1177/1535370214537743.", "ArticleIdList": ["10.1177/1535370214537743", "24912504"]}, {"Citation": "Chen H.-M., Liou S.-F., Hsu J.-H., Chen T.-J., Cheng T.-L., Chiu C.-C., Yeh J.-L. Baicalein Inhibits HMGB1 Release and MMP-2/-9 Expression in Lipopolysaccharide-Induced Cardiac Hypertrophy. Am. J. Chin. Med. 2014;42:785\u2013797. doi: 10.1142/S0192415X14500505.", "ArticleIdList": ["10.1142/S0192415X14500505", "25004875"]}, {"Citation": "Su H., Yao S., Zhao W., Li M., Liu J., Shang W., Xie H., Ke C.-Q., Gao M., Yu K., et al. Discovery of Baicalin and Baicalein as Novel, Natural Product Inhibitors of SARS-CoV-2 3CL Protease in Vitro. bioRxiv. 2020 doi: 10.1101/2020.04.13.038687.", "ArticleIdList": ["10.1101/2020.04.13.038687"]}, {"Citation": "Jo S., Kim S., Shin D.H., Kim M.-S. Inhibition of SARS-CoV 3CL Protease by Flavonoids. J. Enzym. Inhib. Med. Chem. 2019;35:145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Jo S., Kim H., Kim S., Shin D.H., Kim M.-S. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem. Biol. Drug Des. 2019;94:2023\u20132030. doi: 10.1111/cbdd.13604.", "ArticleIdList": ["10.1111/cbdd.13604", "PMC7162010", "31436895"]}, {"Citation": "Zainal N., Chang C.-P., Cheng Y.-L., Wu Y.-W., Anderson R., Wan S.-W., Chen C.-L., Ho T.-S., Abubakar S., Lin Y.-S. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Sci. Rep. 2017;7:42998. doi: 10.1038/srep42998.", "ArticleIdList": ["10.1038/srep42998", "PMC5316936", "28216632"]}, {"Citation": "Andersson U., Wang H., Palmblad K., Aveberger A.-C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., et al. High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes. J. Exp. Med. 2000;192:565\u2013570. doi: 10.1084/jem.192.4.565.", "ArticleIdList": ["10.1084/jem.192.4.565", "PMC2193240", "10952726"]}, {"Citation": "Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin: Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995;270:25752\u201325761. doi: 10.1074/jbc.270.43.25752.", "ArticleIdList": ["10.1074/jbc.270.43.25752", "7592757"]}, {"Citation": "Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.J., Arnold B., Nawroth P., Harris R.A., Harris H.E., Andersson U. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages. Scand. J. Immunol. 2005;61:1\u20139. doi: 10.1111/j.0300-9475.2005.01534.x.", "ArticleIdList": ["10.1111/j.0300-9475.2005.01534.x", "15644117"]}, {"Citation": "Park J.S., Svetkauskaite D., He Q., Kim J.-Y., Strassheim D., Ishizaka A., Abraham E. Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein. J. Biol. Chem. 2003;279:7370\u20137377. doi: 10.1074/jbc.M306793200.", "ArticleIdList": ["10.1074/jbc.M306793200", "14660645"]}, {"Citation": "Meduri G.U., Headley S., Kohler G., Stentz F., Tolley E., Umberger R., Leeper K. Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS. Chest. 1995;107:1062\u20131073. doi: 10.1378/chest.107.4.1062.", "ArticleIdList": ["10.1378/chest.107.4.1062", "7705118"]}, {"Citation": "Sund\u00e9n-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., Lee M.L., Andersson J., Tokics L., Treutiger C.J. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 2005;33:564\u2013573. doi: 10.1097/01.CCM.0000155991.88802.4D.", "ArticleIdList": ["10.1097/01.CCM.0000155991.88802.4D", "15753748"]}, {"Citation": "PubChem.  [(accessed on 18 May 2020)]; Available online:  https://pubchem.ncbi.nlm.nih.gov/"}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "25"}, {"Year": "2020", "Month": "6", "Day": "24"}, {"Year": "2020", "Month": "6", "Day": "29"}, {"Year": "2020", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32629817", "PMC7370028", "10.3390/ijms21134639", "ijms21134639"]}}], "PubmedBookArticle": []}